Benfluorex

DB09022ApprovedWithdrawnSmall molecule

Benfluorex is an anorectic and hypolipidemic agent that is structurally related to fenfluramine. It was patented and manufactured by a French pharmaceutical company Servier. The European Medicines Agency (EMA) recommended... This recommendation was based on the risks (especially fenfluramine-like cardiovascular side-effects) outweighing the benefits.

Chemical structure of Benfluorex
Mechanism
Curator reviewed
Formula / weight
C19H20F3NO2 · 351.3628 g/mol (avg)
Code names
JP 992 · S 780 · SE 780

Resolves to

Compound
UNII403FO0NQG3CAS23602-78-0ChEMBLCHEMBL400599ChEBI93826PubChem2318KEGGD07192
Clinical / RWD
RxNorm18880ATCA10BX06
Structure
InChIKeyCJAVTWRYCDNHSM-UHFFFAOYSA-NSMILESCC(CC1=CC(=CC=C1)C(F)(F)F)NCCOC(=O)C1=CC=CC=C1
Targets
P35610SOAT1

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
610Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
3Marketed productsAcross 1 country and 2 labellers
Sign in
1ATC codeIncluding every combination product, plus 11 drug categories
Sign in
8+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Benfluorex, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In